PREVIOUS
✖
TB Medicine Trial
August 2 , 2019
1943 days
1150
0
- On July 15, 2019 the Indian Council of Medical Research (ICMR) launched India’s first large-scale trial for two new tuberculosis (TB) vaccines.
- There are two vaccines being tested in the latest trial
- Immuvac (also known as mycobacterium indicus pranii or MIP) - manufactured by Cadila Pharmaceuticals in Ahmedabad
- VPM1002 - manufactured by Serum Institute of India in Pune.
- Currently BCG (Bacille Calmette-Guerin) (BCG) vaccine is used.
- But it is over 100 years old and provides poor protection against pulmonary disease in adolescents and adults.
Leave a Reply
Your Comment is awaiting moderation.